» Articles » PMID: 34519991

The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure: Systematic Review and Meta-Analysis

Overview
Journal Obes Surg
Date 2021 Sep 14
PMID 34519991
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to compare bariatric surgery versus non-surgical treatment on blood pressure for patients with obesity. Nineteen RCTs (1353 total patients) were included. In the pooled analyses, bariatric surgery reduces more systolic blood pressure (WMD: - 3.937 mmHg, CI95%: - 6.000 to - 1.875, p < 0.001, I = 0%), diastolic blood pressure (WMD: - 2.690 mmHg, CI95%: - 3.994 to - 1.385, P < 0.001, I = 0%) and more antihypertensives. In subgroup analyses, patients after Roux-en-Y gastric bypass, with poor control of hypertension (BP > 130/80 mmHg) and diabetes mellitus (HbA1C > 7.0%, FPG > 7.0 mmol/L), elder patients (> 45 years), non-severe obesity (BMI < 40 kg/cm, body weight < 120 kg), less waist circumference (< 115 cm) tend to decrease more blood pressure. Besides, patients after surgery also lost more weight (p < 0.001), decreased more waist circumference (p < 0.001), fasting plasma glucose (p < 0.001), glycosylated hemoglobin (p < 0.001), triglycerides (p < 0.001), hsCRP (p = 0.001), increased more high-density lipoprotein cholesterol (p < 0.001), and had better remission of metabolic syndrome (p < 0.001). Changes in total cholesterol, low-density lipoprotein cholesterol, renal function, resting heart rate, and 6-min walking test were not significantly different. Therefore, bariatric surgery is more effective than non-surgical treatment in controlling patients' blood pressure.

Citing Articles

Bariatric Surgery and Remission of Metabolic Syndrome: A Meta-analysis of Randomised Controlled Trials and Prospective Studies.

Dean Y, Mohamed M, Shokri A, Nassar M, Omayer A, Shahid M Obes Surg. 2025; .

PMID: 40000567 DOI: 10.1007/s11695-025-07750-7.


Clinical practice guideline for the management of hypertension in China.

Chin Med J (Engl). 2024; 137(24):2907-2952.

PMID: 39653517 PMC: 11706600. DOI: 10.1097/CM9.0000000000003431.


Weight Loss Therapies and Hypertension Benefits.

Katsi V, Manta E, Fragoulis C, Tsioufis K Biomedicines. 2024; 12(10).

PMID: 39457606 PMC: 11504410. DOI: 10.3390/biomedicines12102293.


Development of the International Federation for Surgery of Obesity and Metabolic Disorders-European Chapter (IFSO-EC) Grade-Based Guidelines on the Surgical Treatment of Obesity Using Multimodal Strategies: Design and Methodological Aspects.

De Luca M, Belluzzi A, Salminen P, Bueter M, Pujol-Rafols J, Sakran N J Clin Med. 2024; 13(17).

PMID: 39274320 PMC: 11396011. DOI: 10.3390/jcm13175106.


The Effects of Bariatric Surgery on the Requirement for Antihypertensive Treatment in Type 2 Diabetes: Insights from a Long-Term Follow-Up Study.

Heald A, Mannan F, Wiltshire R, Ghaffari P, Waheed U, Zdravkovic D Diabetes Ther. 2024; 15(9):2097-2107.

PMID: 39078476 PMC: 11330420. DOI: 10.1007/s13300-024-01627-1.


References
1.
Harsha D, Bray G . Weight loss and blood pressure control (Pro). Hypertension. 2008; 51(6):1420-5. DOI: 10.1161/HYPERTENSIONAHA.107.094011. View

2.
Gajalakshmi V, Lacey B, Kanimozhi V, Sherliker P, Peto R, Lewington S . Body-mass index, blood pressure, and cause-specific mortality in India: a prospective cohort study of 500 810 adults. Lancet Glob Health. 2018; 6(7):e787-e794. PMC: 6005121. DOI: 10.1016/S2214-109X(18)30267-5. View

3.
Arnett D, Blumenthal R, Albert M, Buroker A, Goldberger Z, Hahn E . 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019; 74(10):1376-1414. PMC: 8344373. DOI: 10.1016/j.jacc.2019.03.009. View

4.
Bessesen D, Van Gaal L . Progress and challenges in anti-obesity pharmacotherapy. Lancet Diabetes Endocrinol. 2017; 6(3):237-248. DOI: 10.1016/S2213-8587(17)30236-X. View

5.
Gruber T, Pan C, Contreras R, Wiedemann T, Morgan D, Skowronski A . Obesity-associated hyperleptinemia alters the gliovascular interface of the hypothalamus to promote hypertension. Cell Metab. 2021; 33(6):1155-1170.e10. PMC: 8183500. DOI: 10.1016/j.cmet.2021.04.007. View